Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.
Vanderbilt infectious diseases specialist Thomas Talbot, MD, MPH, answers questions about the current novel coronavirus outbreak in China.
Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.